Juvenile myelomonocytic leukemia (JMML) is a poor-prognosis childhood leukemia usually caused by RAS-pathway mutations. The cellular hierarchy in JMML is poorly characterized, including the identity of leukemia stem cells (LSCs). FACS and single-cell RNA sequencing reveal marked heterogeneity of JMML hematopoietic stem/progenitor cells (HSPCs), including an aberrant Lin-CD34+CD38-CD90+CD45RA+ population. Single-cell HSPC index-sorting and clonogenic assays show that (1) all somatic mutations can be backtracked to the phenotypic HSC compartment, with RAS-pathway mutations as a "first hit,"(2) mutations are acquired with both linear and branching patterns of clonal evolution, and (3) mutant HSPCs are present after allogeneic HSC transplant before molecular/clinical evidence of relapse. Stem cell assays reveal interpatient heterogeneity of JMML LSCs, which are present in, but not confined to, the phenotypic HSC compartment. RNA sequencing of JMML LSC reveals upregulation of stem cell and fetal genes (HLF, MEIS1, CNN3, VNN2, and HMGA2) and candidate therapeutic targets/biomarkers (MTOR, SLC2A1, and CD96), paving the way for LSC-directed disease monitoring and therapy in this disease.

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia / Louka, E.; Povinelli, B.; Rodriguez-Meira, A.; Buck, G.; Wen, W. X.; Wang, G.; Sousos, N.; Ashley, N.; Hamblin, A.; Booth, C. A. G.; Roy, A.; Elliott, N.; Iskander, D.; De La Fuente, J.; Fordham, N.; O'Byrne, S.; Inglott, S.; Norfo, R.; Salio, M.; Thongjuea, S.; Rao, A.; Roberts, I.; Mead, A. J.. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - 218:2(2021), pp. 1-4. [10.1084/JEM.20180853]

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia

Norfo R.;
2021-01-01

Abstract

Juvenile myelomonocytic leukemia (JMML) is a poor-prognosis childhood leukemia usually caused by RAS-pathway mutations. The cellular hierarchy in JMML is poorly characterized, including the identity of leukemia stem cells (LSCs). FACS and single-cell RNA sequencing reveal marked heterogeneity of JMML hematopoietic stem/progenitor cells (HSPCs), including an aberrant Lin-CD34+CD38-CD90+CD45RA+ population. Single-cell HSPC index-sorting and clonogenic assays show that (1) all somatic mutations can be backtracked to the phenotypic HSC compartment, with RAS-pathway mutations as a "first hit,"(2) mutations are acquired with both linear and branching patterns of clonal evolution, and (3) mutant HSPCs are present after allogeneic HSC transplant before molecular/clinical evidence of relapse. Stem cell assays reveal interpatient heterogeneity of JMML LSCs, which are present in, but not confined to, the phenotypic HSC compartment. RNA sequencing of JMML LSC reveals upregulation of stem cell and fetal genes (HLF, MEIS1, CNN3, VNN2, and HMGA2) and candidate therapeutic targets/biomarkers (MTOR, SLC2A1, and CD96), paving the way for LSC-directed disease monitoring and therapy in this disease.
218
2
1
4
Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia / Louka, E.; Povinelli, B.; Rodriguez-Meira, A.; Buck, G.; Wen, W. X.; Wang, G.; Sousos, N.; Ashley, N.; Hamblin, A.; Booth, C. A. G.; Roy, A.; Elliott, N.; Iskander, D.; De La Fuente, J.; Fordham, N.; O'Byrne, S.; Inglott, S.; Norfo, R.; Salio, M.; Thongjuea, S.; Rao, A.; Roberts, I.; Mead, A. J.. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - 218:2(2021), pp. 1-4. [10.1084/JEM.20180853]
Louka, E.; Povinelli, B.; Rodriguez-Meira, A.; Buck, G.; Wen, W. X.; Wang, G.; Sousos, N.; Ashley, N.; Hamblin, A.; Booth, C. A. G.; Roy, A.; Elliott, N.; Iskander, D.; De La Fuente, J.; Fordham, N.; O'Byrne, S.; Inglott, S.; Norfo, R.; Salio, M.; Thongjuea, S.; Rao, A.; Roberts, I.; Mead, A. J.
File in questo prodotto:
File Dimensione Formato  
jem_20180853.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 8.29 MB
Formato Adobe PDF
8.29 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1292009
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 15
social impact